OS Therapies Profitability Analysis

OSTX Stock   5.16  0.05  0.98%   
Based on OS Therapies' profitability indicators, OS Therapies Incorporated may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess OS Therapies' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-7.8 M
Current Value
-8.2 M
Quarterly Volatility
385 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
For OS Therapies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OS Therapies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OS Therapies Incorporated utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OS Therapies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OS Therapies Incorporated over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OS Therapies. If investors know OSTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OS Therapies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
The market value of OS Therapies is measured differently than its book value, which is the value of OSTX that is recorded on the company's balance sheet. Investors also form their own opinion of OS Therapies' value that differs from its market value or its book value, called intrinsic value, which is OS Therapies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OS Therapies' market value can be influenced by many factors that don't directly affect OS Therapies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OS Therapies' value and its price as these two are different measures arrived at by different means. Investors typically determine if OS Therapies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OS Therapies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

OS Therapies Shares Outstanding vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining OS Therapies's current stock value. Our valuation model uses many indicators to compare OS Therapies value to that of its competitors to determine the firm's financial worth.
OS Therapies Incorporated is regarded third in current valuation category among its peers. It is considered to be number one stock in shares outstanding category among its peers creating about  0.23  of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for OS Therapies Incorporated is roughly  4.34 . Common Stock Shares Outstanding is likely to drop to about 16.5 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OS Therapies' earnings, one of the primary drivers of an investment's value.

OSTX Current Valuation vs. Competition

OS Therapies Incorporated is regarded third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 26.75 Billion. OS Therapies adds roughly 90.74 Million in current valuation claiming only tiny portion of equities under Health Care industry.

OSTX Shares Outstanding vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

OS Therapies

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
90.74 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

OS Therapies

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
20.88 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

OSTX Shares Outstanding Comparison

OS Therapies is currently under evaluation in shares outstanding category among its peers.

OS Therapies Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in OS Therapies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, OS Therapies will eventually generate negative long term returns. The profitability progress is the general direction of OS Therapies' change in net profit over the period of time. It can combine multiple indicators of OS Therapies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income-3.4 M-3.6 M
Operating Income-4.3 M-4.6 M
Net Loss-7.8 M-8.2 M
Income Before Tax-7.8 M-8.2 M
Net Loss-7.8 M-8.2 M
Interest Income 2.00  1.10 

OSTX Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on OS Therapies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OS Therapies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OS Therapies' important profitability drivers and their relationship over time.

OS Therapies Profitability Trends

OS Therapies profitability trend refers to the progression of profit or loss within a business. An upward trend means that OS Therapies' profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is OS Therapies' gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

OS Therapies Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between OS Therapies different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards OS Therapies in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down OS Therapies' future profitability.

Use OS Therapies in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OS Therapies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OS Therapies will appreciate offsetting losses from the drop in the long position's value.

OS Therapies Pair Trading

OS Therapies Incorporated Pair Trading Analysis

The ability to find closely correlated positions to OS Therapies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OS Therapies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OS Therapies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OS Therapies Incorporated to buy it.
The correlation of OS Therapies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OS Therapies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OS Therapies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OS Therapies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your OS Therapies position

In addition to having OS Therapies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Chemicals Makers Thematic Idea Now

Chemicals Makers
Chemicals Makers Theme
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.